cellvie at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

cellvie brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on using mitochondria to carry genes into cells without a virus. Topics include in vivo non-viral gene transfer and delivery of COL7A1 that restores collagen VII in a xenograft model of epidermolysis bullosa.

OrganizationESGCT 2026 Attendance
cellvie.bio
Biotech
Develops mitochondria-based therapies to restore cell energy production, plus a mitochondria-mediated platform for non-viral gene delivery.
Poster
Wed Oct 28
1:30pm–3:30pm
Development of a mitochondria-mediated delivery platform for non-viral gene transfer in vivo
Non viral delivery
Poster
Thu Oct 29
2:00pm–4:00pm
Mitochondria-mediated COL7A1 delivery restores collagen VII expression in an epidermolysis bullosa patient cell xenograft model
Non viral delivery

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from cellvie

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction